Resources

iLink Blue User Guide

Professional Provider Office Manual 2024

Professional Provider Office Manual 2025

The BlueCard^® Program Provider Manual 2024

The BlueCard^® Program Provider Manual 2025

Dental Network Provider Manual 2024

Dental Network Provider Manual 2025

Behavioral Health

Blue Connect

Blue HPN

Community Blue

Dental Network

Eligibility and Benefits for BlueCard Members

Federal Employee Program (FEP)

HMOLA Network

HMOLA Preferred Lab

Office of Group Benefits (OGB)

Precision Blue

Preferred Care PPO Network

Preferred Care PPO Lab

Provider Self-service Guide

Registration Guide for iLinkBlue MFA

Signature Blue

Availability Standards

Medical Record Guidelines for BlueCard

Inpatient/Outpatient Authorization Guide

Medicare Crossover Claims

Identification Card Guide

Automated Benefits & Claim Status (IVR Navigation Guide)

Refund Request Guidelines for BlueCard®

A Guide for Understanding APTC Grace Periods

Submitting a Corrected Claim

HEDIS Follow-up After Hospitalization for Mental Illness

CES Tool Guide

Blue Cross Claims Confirmation Reports

Past Workshops
2024 Professional Workshop

2024 Facility Workshop

Recent Webinars
2024 Behavioral Health – ABA

2024 Behavioral Health – Facility

2024 Behavioral Health – Professional

2024 Genetic Testing Program Webinar

2024 New to Blue Webinar - Professional

2024 New to Blue Webinar - Facility

2024 iLinkBlue Webinar

2024 Provider Credentialing and Data Management

2024 BlueCard Webinar

2023 Sleep Management Program Webinar

2022 New Security Setup Application Webinar

2022 Laboratory Benefit Management Program

2019 CES Webinar - Facility

2019 CES Webinar - Professional

2018 ABA WebPass Clinical Review Forms Webinar

2018 Provider Self-service Initiative Webinar

Some forms are available in DocuSign^® format only. When submitting DocuSign documents, please do not separately email them to Louisiana Blue. We automatically receive your submission from the DocuSign application. Double submissions (submitting through DocuSign and also sending an email of the completed form) could delay the processing time for your request. For details on completing DocuSign forms, see the DocuSign Guide under the Quick Links section of this page.

Admissions and Recertifications Form
Alternative Dental Procedure Payment Responsibility Form
Authorization Form
Behavioral Health Provider Clinical Profile Form
Blue Cross CAA Consent Submission Form
Consumer's Right to Know Facility Reporting Form
Continuity of Care Request Form
Coordination of Benefits Questionnaire
       Electronic Funds Transfer Application
Electronic Remittance Advice (ERA) Enrollment Form
       Facility Credentialing Packet
        iLinkBlue Agreement Packet
Itemized Bill Cover Sheet
Maternity Management Referral Form
No Surprises Act Open Negotiation Notice
OGB Bariatric Surgery Form
Overpayment Notification Form
       Professional Initial Credentialing Packet - LSCA
       Professional Initial Credentialing Packet - CAQH
Professional Liability Information Form
Provider Disputes Form
       Provider Update Request Form
Reimbursement During Credentialing
Release of Protected Health Information Form
Retrospective Review Authorization Form
Utilization Management Approval and Denial Fax Form

Effective Jan. 1, 2025
New Medical Policy No. 00898 – Alternative and Complementary Therapy
New Medical Policy No. 00899 – Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux
New Medical Policy No. 00901 – Special Histochemical Stains and Immunohistochemical Stains

Effective Feb. 1, 2025
Revised Medical Policy No. 00583 – Temporomandibular Joint Dysfunction
Revised Medical Policy No. 00684 – Transurethral Water Vapor Thermal Therapy (Rezum) and Transurethral Water Jet Ablation (Aquablation) for Benign Prostatic Hypertrophy

Effective March 1, 2025
Revised Medical Policy No. 00444 – Quantitative Electroencephalography as a Diagnostic Aid for Attention-Deficit/Hyperactivity Disorder, Cognitive Impairment or Autism Spectrum Disorder
Revised Medical Policy No. 00819 – Granulocyte Colony Stimulating Factor (G-CSF) Products

Revised Policy
Effective for dates of service on and after July 15, 2024:

• Policy No. G2022 – Biomarker Testing for Autoimmune Rheumatic Disease
• Policy No. G2124 – Serum Tumor Markers for Malignancies

Effective for dates of service on and after March 15, 2025:

• Policy No. G2036 – Hepatitis Testing
• Policy No. G2045 – Thyroid Disease Testing
• Policy No. G2110 – Serum Testing for Hepatic Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease
• Policy No. G2149 – Pathogen Panel Testing
• Policy No. G2153 – Pancreatic Enzyme Testing for Acute Pancreatitis
• Policy No. G2155 – General Inflammation Testing
• Policy No. G2157 – Diagnostic Testing of Common Sexually Transmitted Infections
• Policy No. G2158 – Testing for Vector-Borne Infections
• Policy No. M2068 – Testing for Alpha-1 Antitrypsin Deficiency
• Policy No. M2097 – Identification of Microorganisms using Nucleic Acid Probes

New Policies
Effective for dates of service on and after March 15, 2025:

• Policy No. G2151 – Serum Testing for Evidence of Mild Traumatic Brain Injury

• Policy No. G2043 – Celiac Disease Testing
• Policy No. G2051 – Bone Turnover Markers Testing
• Policy No. G2059 – Epithelial Cell Cytology in Breast Cancer Risk Assessment
• Policy No. G2157 – Diagnostic Testing of Common Sexually Transmitted Infections
• Policy No. G2159 - β-Hemolytic Streptococcus Testing

Humira Biosimilar Coverage Overview